acetylcysteine has been researched along with Libman-Sacks Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Abbasifard, M; Askari, PS; Khorramdelazad, H; Najafizadeh, SR; Parizi, MK; Rezaian, M; Rostamian, A; Sharifi, GTK; Sharifi, MTK | 1 |
| Heng, TYJ; Mak, A; Tan, MKX | 1 |
| Barosa, R; Fonseca, C; Freitas, J; Ramos, LR | 1 |
| Doherty, E; Oaks, Z; Perl, A | 1 |
| Avellini, C; De Vita, S; Maset, M; Quartuccio, L; Soardo, G | 1 |
| Aleksiejuk, P; Banki, K; Bonilla, E; Francis, L; Landas, SK; Liu, Y; Marchena-Mendez, I; Oaks, Z; Patel, J; Perl, A; Yu, J | 1 |
| Barnado, A; Crofford, LJ; Oates, JC | 1 |
| Aguirre, MA; Barbarroja, N; Collantes-Estevez, E; Cuadrado, MJ; Jimenez-Gomez, Y; López-Pedrera, C | 1 |
| Banki, K; Huang, N; Oaks, Z; Perl, A; Winans, T | 1 |
| Mannargudi, B; McNally, D; Reynolds, W; Uetrecht, J | 1 |
| Bartos, A; Bonilla, E; Caza, TN; Clair, B; Coman, I; Dawood, M; Doherty, E; Faraone, SV; Francis, L; Garcia, R; Hanczko, R; Jimah, J; Lai, ZW; Miklossy, G; Perl, A; Phillips, PE; Ramos, I; Tily, H; Yu, J | 1 |
| Dawood, M; Faraone, SV; Francis, L; Garcia, RJ; Lai, ZW; Perl, A | 1 |
| Keisler, D; Lagoo, A; McMurray, RW; Suwannaroj, S | 1 |
4 review(s) available for acetylcysteine and Libman-Sacks Disease
| Article | Year |
|---|---|
The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus.
Topics: Acetylcysteine; Chemotherapy, Adjuvant; Dipyridamole; Drug Therapy, Combination; Humans; Lupus Erythematosus, Systemic; Metformin | 2019 |
At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.
Topics: Acetylcysteine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antimalarials; Apoptosis; Atherosclerosis; Autoantigens; Autoimmune Diseases; Biomarkers; Deoxyribonuclease I; Extracellular Traps; Female; Humans; Hydrolases; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Systemic; Molecular Targeted Therapy; Neutrophils; Pregnancy; Pregnancy Complications; Protein Processing, Post-Translational; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Thrombophilia; Thrombosis; Translational Research, Biomedical; Vitamin D | 2016 |
Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches.
Topics: Acetylcysteine; Anticoagulants; Antioxidants; Antiphospholipid Syndrome; Atherosclerosis; Autoantibodies; beta 2-Glycoprotein I; Coagulants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lupus Erythematosus, Systemic; Mitochondrial Diseases; Oxidative Stress; Reactive Oxygen Species; Recurrence; Thrombosis; Ubiquinone | 2016 |
Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.
Topics: Acetylcysteine; B-Lymphocytes; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Sirolimus; T-Lymphocytes; TOR Serine-Threonine Kinases | 2016 |
3 trial(s) available for acetylcysteine and Libman-Sacks Disease
| Article | Year |
|---|---|
Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: a randomized double-blind clinical trial study.
Topics: Acetylcysteine; Double-Blind Method; Humans; Kidney; Lupus Erythematosus, Systemic; Severity of Illness Index; Treatment Outcome | 2023 |
N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Topics: Acetylcysteine; Adult; Double-Blind Method; Female; Free Radical Scavengers; Humans; Lupus Erythematosus, Systemic; Male; Membrane Potential, Mitochondrial; Middle Aged; Pilot Projects; Placebos; Severity of Illness Index; T-Lymphocytes; TOR Serine-Threonine Kinases; Treatment Outcome | 2012 |
Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Aged; Attention Deficit Disorder with Hyperactivity; Early Diagnosis; Female; Free Radical Scavengers; Health Status; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Neuropsychological Tests; Self Report; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2013 |
6 other study(ies) available for acetylcysteine and Libman-Sacks Disease
| Article | Year |
|---|---|
Acute hepatitis in a young woman with systemic lupus erythematosus: a diagnostic challenge.
Topics: Acetylcysteine; Biopsy; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Hepatitis, Autoimmune; Humans; Liver Function Tests; Lupus Erythematosus, Systemic; Middle Aged | 2013 |
Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Aged; Cells, Cultured; Electron Transport Complex I; Female; Humans; Hydrogen Peroxide; Lupus Erythematosus, Systemic; Lymphocytes; Middle Aged; Oxygen Consumption; Young Adult | 2014 |
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus.
Topics: Acetaminophen; Acetylcysteine; Adult; Biopsy; Chemical and Drug Induced Liver Injury; Female; Fever; Glucocorticoids; Humans; Liver; Lupus Erythematosus, Systemic; Prednisone; Treatment Outcome | 2014 |
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Azathioprine; Biomarkers; Cohort Studies; Complement System Proteins; Cyclosporine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Liver Diseases; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sirolimus | 2015 |
Bioactivation of minocycline to reactive intermediates by myeloperoxidase, horseradish peroxidase, and hepatic microsomes: implications for minocycline-induced lupus and hepatitis.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Biotransformation; Chromatography, High Pressure Liquid; Free Radical Scavengers; Free Radicals; Hepatitis, Autoimmune; Horseradish Peroxidase; In Vitro Techniques; Lupus Erythematosus, Systemic; Magnetic Resonance Spectroscopy; Male; Microsomes, Liver; Minocycline; Oxidation-Reduction; Peroxidase; Rats; Rats, Inbred BN; Tandem Mass Spectrometry | 2009 |
Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE).
Topics: Acetylcysteine; Adjuvants, Immunologic; Animals; Antioxidants; Cysteamine; Female; Free Radical Scavengers; Humans; Lupus Erythematosus, Systemic; Mice; Radiation-Protective Agents; T-Lymphocytes | 2001 |